EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficient Sensing of a 4-Segmented Rift Valley Fever Virus Vaccine Candidate by Human Monocytes

Niranjana Nair iD, Julia Friese, Paul J Wichgers Schreur iD, Albert D M E Osterhaus iD, Guus F Rimmelzwaan, Chittappen Kandiyil Prajeeth iD

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiag085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Niranjana Nair und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover Foundation, Germany. Hauptthemen laut MEDLINE: Monocytes, Rift Valley fever virus, Viral Vaccines, Rift Valley Fever. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, University of Veterinary Medicine Hannover Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The live-attenuated RVFV-4s vaccine against Rift Valley fever has demonstrated safety and efficacy across multiple animal models and in a phase 1 clinical trial. In this study, we examined its impact on innate immune responses and found that RVFV-4s enhances the expression of costimulatory molecules critical for T-cell activation, while triggering proinflammatory responses in primary human monocytes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MonocytesRift Valley fever virusViral VaccinesRift Valley FeverHumansImmunity, InnateT-LymphocytesVaccines, AttenuatedLymphocyte Activation

Stichwörter der Autor:innen

M1 macrophageRVFV-4sT-cell activationmonocyteproinflammatory response

Substanzen

Viral VaccinesVaccines, Attenuated

Autor:innen und Institutionen

  • Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover Foundation, Germany.
  • Department of Virology and Molecular Biology, Wageningen Bioveterinary Research, Wageningen University & Research, Lelystad, Netherlands.

ORCID-Profile: Niranjana Nair, Paul J Wichgers Schreur, Albert D M E Osterhaus, Chittappen Kandiyil Prajeeth

Förderung

  • Deutsche Forschungsgemeinschaft
  • University of Veterinary Medicine Hannover Foundation

Zitieren

APA

Nair, N., Friese, J., Wichgers Schreur, P. J., Osterhaus, A. D. M. E., Rimmelzwaan, G. F., & Prajeeth, C. K. (2026). Efficient Sensing of a 4-Segmented Rift Valley Fever Virus Vaccine Candidate by Human Monocytes. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag085

Vancouver

Nair N, Friese J, Wichgers Schreur PJ, Osterhaus ADME, Rimmelzwaan GF, Prajeeth CK. Efficient Sensing of a 4-Segmented Rift Valley Fever Virus Vaccine Candidate by Human Monocytes. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag085

BibTeX
@article{Nair2026,
  author = {Nair, Niranjana and Friese, Julia and Wichgers Schreur, Paul J and Osterhaus, Albert D M E and Rimmelzwaan, Guus F and Prajeeth, Chittappen Kandiyil},
  title = {Efficient Sensing of a 4-Segmented Rift Valley Fever Virus Vaccine Candidate by Human Monocytes},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiag085}
}
Kostenlos starten →